Overexpression of the MET receptor tyrosine kinase in tumors with TFE3 gene fusions

被引：0
|
作者：
Argani, P
Tsuda, M
Chen, MS
Edgar, M
Ladanyi, M
机构：
[1] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
LABORATORY INVESTIGATION | 2006年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1381
引用
收藏
页码：297A / 297A
页数：1
相关论文
共 50 条
  • [1] Overexpression of the MET receptor tyrosine kinase in tumors with TFE3 gene fusions
    Argani, P
    Tsuda, M
    Chen, MS
    Edgar, M
    Ladanyi, M
    MODERN PATHOLOGY, 2006, 19 : 297A - 297A
  • [2] A Subset of PEComas Harbor TFE3 Gene Fusions
    Argani, P.
    Illei, P.
    Netto, G.
    Ro, J.
    Cho, H. Y.
    Dogan, S.
    Ladanyi, M.
    Martignoni, G.
    Aulmann, S.
    Weiss, S. W.
    LABORATORY INVESTIGATION, 2010, 90 : 15A - 15A
  • [3] A Subset of PEComas Harbor TFE3 Gene Fusions
    Argani, P.
    Illei, P.
    Netto, G.
    Ro, J.
    Cho, H. Y.
    Dogan, S.
    Ladanyi, M.
    Martignoni, G.
    Aulmann, S.
    Weiss, S. W.
    MODERN PATHOLOGY, 2010, 23 : 15A - 15A
  • [4] A Distinctive Subset of PEComas Harbors TFE3 Gene Fusions
    Argani, Pedram
    Aulmann, Sebastian
    Illei, Peter B.
    Netto, George J.
    Ro, Jae
    Cho, Hyun-yee
    Dogan, Snjezana
    Ladanyi, Marc
    Martignoni, Guido
    Goldblum, John R.
    Weiss, Sharon W.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2010, 34 (10) : 1395 - 1406
  • [5] Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions -: A sensitive and specific immunohistochemical assay
    Argani, P
    Lal, P
    Hutchinson, B
    Lui, MY
    Reuter, VE
    Ladanyi, M
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2003, 27 (06) : 750 - 761
  • [6] Prominent nuclear immunoreactivity for TFE3 as a specific marker for alveolar soft part sarcoma and pediatric renal tumors containing TFE3 gene fusions
    Ladanyi, M
    Argani, P
    Hutchinson, B
    Reuter, VE
    LABORATORY INVESTIGATION, 2002, 82 (01) : 312A - 312A
  • [7] Prominent nuclear immunoreactivity for TFE3 as a specific marker for alveolar soft part sarcoma and pediatric renal tumors containing TFE3 gene fusions
    Ladanyi, M
    Argani, P
    Hutchinson, B
    Reuter, VE
    MODERN PATHOLOGY, 2002, 15 (01) : 312A - 312A
  • [8] TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition
    Tsuda, Masumi
    Davis, Ian J.
    Argani, Pedram
    Shukla, Neerav
    McGill, Gael G.
    Nagai, Makoto
    Saito, Tsuyoshi
    Lae, Marick
    Fisher, David E.
    Ladanyi, Marc
    CANCER RESEARCH, 2007, 67 (03) : 919 - 929
  • [9] Diagnostic approach of tumors with neurotrophic tropomyosin receptor tyrosine kinase gene fusions
    Lippai Zoltan
    Sapi Zoltan
    ORVOSI HETILAP, 2020, 161 (41) : 1753 - 1763
  • [10] Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions
    Martignoni, Guido
    Gobbo, Stefano
    Camparo, Philippe
    Brunelli, Matteo
    Munari, Enrico
    Segala, Diego
    Pea, Maurizio
    Bonetti, Franco
    Illei, Peter B.
    Netto, Georges J.
    Ladanyi, Marc
    Chilosi, Marco
    Argani, Pedram
    MODERN PATHOLOGY, 2011, 24 (10) : 1313 - 1319
12345